Global Cord Blood Corp operates in the Health and allied services sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Global Cord Blood Corp with three other
health care providers in Asia:
Cedar Company Ltd
sales of 14.26 billion Japanese Yen [US$131.32 million]
of which 69%
was Facility Service),
Charm Care Corp
(16.56 billion Japanese Yen [US$152.52 million]
of which 100%
was Nursing care business), and
Health Management International Limited
based in Singapore
(168.31 million Singapore Dollars [US$123.85 million]
Global Cord Blood Corp reported sales of 986.75 million Chinese Renmimbi (US$140.19 million)
March of 2019.
increase of 5.3%
versus 2018, when the company's sales were 936.77 million Chinese Renmimbi.
Sales at Global Cord Blood Corp have increased during each of the previous five years
(and since 2014, sales have increased a total of 72%).